Catheter Precision (VTAK) Short-term Investments (2019 - 2025)

Catheter Precision (VTAK) posted quarterly Short-term Investments of $981000.0 for Q3 2025, up 12.24% quarter-over-quarter from $874000.0 in Q2 2025.

Catheter Precision (VTAK) Short-term Investments (2019 - 2025) Analysis & Trends

Catheter Precision (VTAK) has reported Short-term Investments for 3 consecutive years, with $981000.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Short-term Investments changed N/A year-over-year to $981000.0; the TTM figure through Sep 2025 stood at $981000.0 (changed N/A YoY), while the FY2019 annual figure was $16.0 million, changed N/A from the prior year.
Short-term Investments improved to $981000.0 in Q3 2025 per VTAK's latest filing, from $874000.0 in the prior quarter.
Across five years, Short-term Investments topped out at $981000.0 in Q3 2025 and bottomed at $874000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.46 Bn	193.86 Bn	7.27 Bn
2	Stryker	127.41 Bn	123.93 Bn	4.50 Bn
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn
5	Edwards Lifesciences	51.95 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.30 Bn	32.35 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn
8	Koninklijke Philips	26.35 Bn	23.02 Bn	4.55 Bn
9	Steris	23.04 Bn	22.55 Bn	684.20 Mn
10	Catheter Precision	575,627.53	-1.26 Mn	98,000.00

Download Data